Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study

This publication has 31 references indexed in Scilit:

• Effect of long‐acting β₂ agonists on exacerbation rates of asthma in children
  Pediatric Pulmonology, 2003
• The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
  Respiratory Medicine, 2003
• Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
  European Respiratory Journal, 2002
• Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients
  Clinical and Experimental Allergy, 2002
• Montelukast: Data from Clinical Trials in the Management of Asthma
  Annals of Pharmacotherapy, 1999
• Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
  BMJ, 1999
• Systemic Adverse Effects of Inhaled Corticosteroid Therapy
  Archives of internal medicine (1960), 1999
• Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
  New England Journal of Medicine, 1997
• Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
  The Lancet, 1994